| |
|
|
| |
Continuous Glucose Monitors
Evolving Technology, Emerging Opportunities
|
Publication: October 2011
Product Code: CGM721K
|
The convergence of small-scale electronics and sophisticated
biocompatible product designs is giving hope for a better
future to millions of diabetes patients worldwide.
Continuous glucose monitors that are designed to be
implanted and can continually measure glucose levels have
the capability to improve glycemic control and patient
wellbeing. By integrating the sensing element, electronics,
and a power source in a single package, implantable monitors
are creating new options for caregivers and their diabetes
patients. Signal processing improvements - include improved
signal-to-noise ratios and interference filtering - will
continue to be critical to the commercialization prospects
of implantable monitors. While the potential is substantial,
for most participants the road to commercialization will
contain numerous speed bumps and delays that will strain
capitalization requirements and investor patience.
Successful players will be those that realize the value of
partnerships and strategic alliances. |
|
Highlights |
· Analyzes and evaluates
continuous glucose sensing and monitoring technologies
and assesses the market potential for existing and
probable future products
· Examines continuous
glucose monitor design issues and evolving market
factors
· Provides detailed
status of continuous glucose monitors currently in
development
· Forecasts the impact of
continuous glucose sensing technology and devices on
diabetes management markets and projects probable future
developments
· Profiles market
participants, their technology, product
development activity, and business
strategies
|
|
Summary of Contents |
Executive Summary
Diabetes Management
Market Overview
Diabetes Economics
Monitoring Glucose Levels
Key Factors in Patient
Compliance
Market Drivers
Industry Alignment
and Competitive Landscape
New Generation
Monitor Technology and Design Factors
Measuring Interstitial Fluid
Durability/Reliability
Sensor Life
Wireless
Technology
Commercialization Factors
Data Collection & Display
Accuracy & Precision
Sensor Insertion
Patient/User Interface
Market Factors
PMA Medical Device
Approval
Clinical Trials
Standards,
Regulation & Guidance
Patient/Consumer Sentiment
Design Partnerships
Shifting Diabetes
Demographics
FDA-Approved Continuous
Monitors – Analysis & Market Impact
Dexcom 7 Plus
Freestyle Navigator
Guardian RT CGM
Minimed
Paradigm RT Revel
Development-stage
Monitoring Devices – Assessment and Prospects
Ambulatory
GlucoChip (PositiveID/ReceptorsLLC)
Glucowizzard (Bio-Orasis)
GluSense
MicroCHIPS
SMSI
Solianis
In-Patient
DIRAmed
Symphony tCGM
Sector Participant Company
Profiles
|
|
|
|
|
